The primary advantage of precision oncology is its potential to significantly improve treatment outcomes. By tailoring therapy to the molecular profile of a patient's cancer, treatments can be more effective and potentially less toxic. This precision reduces the trial-and-error approach commonly associated with conventional treatments, thereby saving time and reducing patient suffering. Furthermore, the identification of specific genetic mutations can offer insights into the prognosis and help in monitoring disease progression.
